Cistema launches Hela, a clinical-grade medical AI reference

Cistema Pte. Ltd. has launched Hela, a medicine reference designed to trace every answer to a source and keep content current through clinician editors and AI agents. The product is aimed at doctors in practice and training across web, iOS and Android, as pressure grows for AI tools that can show where medical answers come from.

Why it matters: - Clinicians are already using AI chatbots for quick medical lookups, but generic tools can be outdated, inconsistent and unable to show the source of an answer. - Hela is built to raise the bar for medical reference tools by tying every statement to a cited source and a named clinician reviewer. - The product is designed for fast-moving topics where guidance changes often, including obesity management and PCOS.

What happened: - Cistema Pte. Ltd., a Singapore-based healthcare AI company, launched Hela on October 8, 2026. - Hela is a clinical-grade AI reference available to doctors in practice and in training on the web, iOS and Android. - Hela is described as a single verified source of truth for medicine.

The details: - Hela is built by two groups working together: AI agents and named clinician editors. - The AI agents scan for guideline changes, flag content that may be out of date and check statements against the literature. - Clinician editors review and approve every change before readers see it. - Every statement in Hela is signed off by a clinician and cites its sources. - Hela’s AI search answers clinical questions in plain language using only verified Hela content. - Search results include references to the passages used to generate the answer. - Hela does not pull answers from the open internet. - The launch features include traceable statements, continuously monitored literature updates, grounded AI search, linked content across conditions, drugs and investigations, and structured plain-language entries for quick lookups on a phone. - Hela is open to contributors, including clinicians who want to share notes, suggest corrections or apply to become editors. - Cistema also points users to the company’s LinkedIn page and Hela’s Instagram account.

Between the lines: - The launch reflects a broader push to make medical AI auditable, rather than just fluent. - The company is positioning human clinical oversight as the trust layer, with AI agents handling continuous monitoring and update detection. - The emphasis on citations and named reviewers suggests Hela is aimed at high-stakes clinical decision support, not general consumer Q&A.

What’s next: - Hela will soon be available at hela.org. - Cistema says clinicians will be able to keep contributing notes and corrections as the knowledge base expands. - The product will need to prove that its update process can keep pace with changing medical guidance in real time.

The bottom line: - Cistema is betting that clinicians want AI speed without sacrificing source traceability, editorial oversight or freshness.